July 6 (Reuters) - Australia's Therapeutic Goods Administration (TGA):
- AUSTRALIA'S TGA GRANTS PROVISIONAL DETERMINATIONS TO PFIZER FOR COVID-19 VACCINES TO TARGET OMICRON VARIANT
- DETERMINATIONS REFER TO MONOVALENT COVID-19 VACCINE RILTOZINAMERAN, BIVALENT COVID-19 VACCINE TOZINAMERAN & RILTOZINAMERAN
- 2 NEW PROVISIONAL DETERMINATIONS MEAN PFIZER AUSTRALIA CAN APPLY TO TGA FOR PROVISIONAL REGISTRATION FOR COMIRNATY OMICRON AND BIVALENT VACCINES
(([email protected];))
